Adare Pharma Solutions, a global, technology-driven contract development and manufacturing organization, or CDMO, with a U.S. corporate office in Lawrenceville, has appointed Tom Sellig as its CEO.
Sellig, a 30-year veteran of the pharmaceutical and life sciences industries, will lead the organization in supporting pharmaceutical companies in the development and manufacturing of transformative medicines that improve patient health and outcomes.
“Tom’s track record of driving commercial and operational excellence in pharmaceutical services uniquely prepares him to lead Adare, at a moment when pharmaceutical companies are increasingly seeking partners to solve their most complex formulation and commercialization challenges,” said Vivek Sharma, who resumes his position as chairman and a board director after serving as the company’s interim CEO.
Adare offers technology-driven solutions to solve pharmaceutical companies’ challenges, from product development to commercial scale manufacturing and packaging.
Adare has developed proprietary technologies that enable the production of critical pharmaceuticals, including technologies for taste masking, controlled release and precision injectable delivery. Additionally, Adare’s recently expanded service offerings include a high-potency suite for pilot and commercial scale high-potency projects and extensive packaging capabilities, from high-speed bottle filling to stick pack and blister packaging.
“This is a watershed moment when pharmaceutical and biotech companies are introducing transformative medications into market,” Sellig said. “Adare has developed innovative solutions that make these medicines more widely and readily available to patients through our partnerships with leading pharmaceutical companies. I could not be more excited to join such a talented team as we help widen access to critical health care.”
Sellig brings 30 years of executive experience in life sciences. He served as CEO of LabConnect, a leading global provider of central laboratory and support services for the biopharmaceutical industry. Prior to LabConnect, Sellig was chief commercial officer at ConnectiveRx, where he was responsible for all commercial and customer-facing activity at the patient-support and patient-access company. Before joining ConnectiveRx, he served as senior vice president of global sales at Patheon, where he played an integral role in the company’s sale to and integration with Thermo Fisher. Earlier in his career, he served as global vice president of sales and client services at Covance.
